People with type 2 diabetes often struggle with sleep apnea, a condition where breathing repeatedly stops and starts during sleep. A recent study looked into whether a type of diabetes medication, called SGLT2 inhibitors, could help with this problem. The study gathered data from many different sou
People with type 2 diabetes often take special medicines. Two of these are GLP-1 receptor agonists and SGLT2 inhibitors. Both help control blood sugar. But do they affect the risk of leg amputations differently? A big study looked at this question. It compared new users of these two types of drugs.
The effects of sodium-glucose cotransporter 2 (SGLT2) inhibitors on body composition in people with type 2 diabetes (T2D) can vary greatly depending on age. This was the focus of a recent study that tracked changes in body mass index (BMI), body fat percentage, and muscle mass over an average of 4.
A study was conducted to see how well new diabetes medications work. One hundred patients with type 2 diabetes were involved. The focus was on how these drugs affect two specific health markers. The first marker is the ratio of triglycerides to HDL cholesterol. The second is the triglyceride-glu
Cisplatin is a powerful tool in the fight against cancer. It is a chemotherapy drug that can be very effective. However, it has a downside. It can cause the kidneys to lose too much magnesium. This can lead to a condition called hypomagnesemia. This is a big problem because magnesium is crucial for
Imagine you have two tough health issues: type 2 diabetes (T2D) and chronic kidney disease (CKD). Doctors are finding new ways to treat these conditions, especially with a special kind of pill called an SGLT2 inhibitor. These pills are getting lots of attention in Europe, Japan, and the US. The FOU
You might have heard about SGLT2 inhibitors, a type of medicine used to manage type 2 diabetes. But did you know they can increase the risk of genitourinary tract infections? A recent study dug deep into this topic, focusing on both first-time and recurring infections in patients taking these drugs.
